Kidney
Function Tests
|
Tests for GFR
|
Clearance:
-Inulin clearance
-Creatinine clearance
-Urea clearance
Phenolsulfonphthalein dye test
Cystatin C
|
Tests for Renal Blood Flow
|
BUN
Creatinine
Uric acid
|
Tests Measuring Tubular Function
|
Excretion:
-Para-amino hippurate test (Diodrast test)
-Phenolsulfonphthalein dye test
Concentration:
-Specific gravity
-Osmolality
|
GFR
|
Decreases by 1.0 mL/min/year after age
20-30 years
150 L of glomerular filtrate is produced
daily
|
Inulin clearance
|
Reference method
|
Creatinine clearance
|
Best alternative method
Measure of the completeness of a 24-hour
urine collection
Excretion: 1.2-1.5 g creatinine/day
|
Urea clearance
|
Demonstrate progression of renal disease or
response to therapy
|
Cystatin C
|
Low MW protease inhibitor
Filteredà Not secretedà Completely reabsorbed (PCT)
Indirect estimates of GFR
Its presence in urine denotes damage to PCT
|
BUN
|
Synthesized from Ornithine or Kreb’s Henseleit
cycle
First metabolite to elevate in kidney
diseases
Better indicator of nitrogen intake and
state of hydration
|
2.14
|
BUN Ã Urea (mg/dL)
|
Fluoride or citrate
|
Inhibit urease
|
Thiosemicarbazide
Ferric ions
|
Enhance color development (BUN mtd)
|
Diacetyl monoxime method
|
Yellow diazine derivative
|
Urease method
|
Routinely used
Urease: prepared from jack beans
Urea ---(Urease)--> NH4 +
Berthelot reagent (Measure ammonia)
|
Coupled urease
|
Glutamate dehydrogenase method
UV enzymatic method
|
Isotope dilution mass spectrometry
|
Reference method
For research purposes
|
NPN
|
45% Urea
20% Amino acid
20% Uric acid
5% Creatinine
1-2% Creatine
0.2% Ammonia
|
Creatinine
|
Derived from alpha-methyl guanidoacetic
acid (creatine)
Produced by 3 amino acids (methionine,
arginine, lysine)
Most commonly used to monitor renal
function
|
Enzymatic methods
(Creatinine)
|
Creatinine Aminohydrolase – CK method
Creatinase-Hydrogen Peroxide method –
benzoquinonemine dye (red)
Creatininase (a.k.a. creatinine
aminohydrolase)
|
Direct Jaffe method
|
Formation of red tautomer of creatinine
picrate
|
Interferences (Direct Jaffe)
|
Falsely increased:
Ascorbate
Glucose
Uric acid
Alpha-keto acids
|
Folin Wu Method
|
(+) Red orange tautomer
|
Lloyd’s or Fuller’s Earth method
|
True measure of creatinine
Sensitive and specific
Uses adsorbent to remove interferences (UA,
Hgb, Bili)
|
Lloyd’s reagent
|
Sodium aluminum silicate
|
Fuller’s earth reagent
|
Aluminum magnesium silicate
|
Jaffe reagent (Alk. picrate)
|
Satd. picric acid + 10% NaOH
|
Kinetic Jaffe method
|
Popular, inexpensive, rapid and easy to
perform
Requires automated equipment
|
Azotemia
|
Elevated urea and creatinine in blood
|
Pre-renal azotemia
|
Decreased GFR but normal renal function
Dehydration, shock, CHF
Increased: BUN
Normal: Creatinine
|
Renal azotemia
|
True renal disease
Decreased GFR
Striking BUN level but slowly rising
creatinine value
BUN = >100 mg/dL
Creatinine = >20 mg/dL
Uric acid = >12 mg/dL
|
Post renal azotemia
|
Urinary tract obstruction
Decreased GFR
Nephrolithiasis, cancer or tumors of GUT
Creatinine = normal or slightly increased
|
Uremia
|
Marked elevation of urea, accompanied by
acidemia and electrolyte imbalance (K+ elevation) of renal failure
Normocytic, normochromic anemia
Uremic frost (dirty skin)
Edema
Foul breath
Urine-like sweat
|
Uric acid
|
From purine (adenine and guanine)
catabolism
Excretion: 1g/day
|
Hyperuricemia
|
-Gout
-Increased nuclear metabolism (leukemia,
lymphoma, MM, polycythemia, hemolytic and megaloblastic anemia) – Tx:
Allopurinol
-Chronic renal disease
-Lesch-Nyhan syndrome (HGPRT deficiency)
|
Hypouricemia
|
Fanconi’s syndrome
Wilson’s disease
Hodgkin’s disease
|
Methods (Uric acid)
|
Stable for 3 days
Potassium oxalate cannot be used
Major interferences: Ascorbate and
bilirubin
|
Phosphotungstic acid mtd
|
Uric acid + Phosphotungstic acid
---(NaCN/NaCO3)--> Tungsten blue + Allantoin
|
NaCN
|
Folin
Newton
Brown
Benedict
|
NaCO3
|
Archibald
Henry
Caraway
|
Lagphase
|
Incubation period after the addition of an
alkali to inactivate non-uric acid reactants
|
Uricase method
|
Simplest and most specific method
Candidate reference method
Uric acid (Absorbance at 293nm)
---[Uricase]--> Allantoin (No absorbance)
Decrease in absorbance α uric acid
concentration
|
Para-amino hippurate test
|
Measures renal plasma flow
Reference method for tubular function
|
Phenolsulfonphthalein dye test
|
Measures excretion of dye proportional to
renal tubular mass
6 mg of PSP is administered IV
|
Concentration tests
|
Collecting tubules and loops of Henle
Specimen: 1st morning urine
|
Specific gravity
|
Affected by solute number and mass
SG >1.050: X-ray dye and mannitol
1.010 = SG of ultrafiltrate in Bowman’s
space
|
Osmolality
|
Total number solute particles present/kg of
solvent (moles/kg solvent)
Affectted only by number of solutes present
Urine osmolality = due to urea
Serum osmolality = due to sodium and
chloride
Det. by Colligative properties:
Freezing point (incr. osm. = decr. FP)
Vapor pressure (incr. osm. = decr. VP)
Osmotic pressure (incr. osm. = incr. OP)
Boiling point (incr. osm. = incr. BP)
|
Direct methods (Osmolality)
|
Freezing point osmometry = popular method
Vapor pressure osmometry (Seebeck effect)
|
Incr. plasma osmolality
|
Incr. vasopressin (H2O
reabsorption) Ã decr. plasma osmolality
|
Tubular failure
|
Increased: BUN, creatinine, calcium
Decreased: Phosphate
|
Osmolal gap
|
Difference between measured and calculated
osmolality
Sensitive indicator of alcohol or drug
overdose
|
Osmolal gap: >12 mOsm/kg
|
DKA
Drug overdose
Renal failure
|
Normal Values
(Kidney Function Tests)
|
Creatinine Clearance:
Male = 85-125 mL/min
Female = 75-112 mL/min
BUN = 8-23 mg/dL
Creatinine = 0.5-1.5 mg/dL
Uric acid:
Male = 3.5-7.2 mg/dL
Female = 2.6-6.0 mg/dL
Renal plasma flow (PAH) = 600-700 mL/min
Renal blood flow (PSP) = 1200 mL/min
SG = 1.005-1.030
Osmolality:
Serum = 275-295 mOsm/kg
Urine (24-hr) = 300-900 mOsm/kg
[<290 mOsm/kg = kidney damage]
Urine osmolality: Serum osmolality = 1:1 to 3:1
[>1:1 = Glomerular disease]
[1.2:1 = loss of renal concentrating
ability]
[<1:1 = Diabetes Insipidus]
|
Liver
Function Tests
|
Liver
|
Receives 15 mL of blood per minute
Lobule: anatomic unit
|
Synthetic function
|
Proteins, CHO, lipids, LPP, clotting
factors, ketone bodies, enzymes
Albumin: 12g/day
|
Conjugation function
|
Bilirubin metabolism
Bilirubin: 200mg/day
|
Detoxification and Drug metabolism
|
Drugs
Ammonia à Urea à Excreted
|
Excretory and Secretory functions
|
Bile acids: cholic acid and
chenodeoxycholic acid
Bile salts: bile acids + amino acids
(glycine and taurine)
|
Storage function
|
Vitamins
Glycogen
|
Test measuring the Hepatic Synthetic Ability
|
Total Protein Determination:
-Kjeldahl method
-Biuret method
-Folin-Ciocalteu (Lowry) method
-UV absorption method
-Electrophoresis
-Refractometry
-Turbidimetric and Nephelometric methods
-Salt fractionation
Prothrombin Time (Vitamin K Response Test)
|
Test measuring Conjugation/Excretion Function
|
Bilirubin Assay:
-Evelyn and Malloy method
-Jendrassik and Grof
Bromsulfonphthalein (BSP) Dye Excretion
test
|
Test for Detoxification Function
|
Enzyme tests: ALP, AST, ALT, 5’NT, GGT, OCT, LAP, LDH
Ammonia:
-Kjeldahl (Digestion) method
-Nesslerization reaction
-Berthelot reaction
|
Plasma protein
|
0.2-0.4 g/dL higher than serum due to
fibrinogen
|
Kjeldahl (Digestion) mtd
|
Standard reference method
Measurement of nitrogen content
Serum + Tungstic acid à PFF
1g N2 = 6.54g protein
15.1-16.8% = N2 content of
proteins
Rgt: H2SO4
End product: NH3
|
Biuret method
|
Most widely used method (IFCC recommended)
Req. at least 2 peptide bonds and an
alkaline medium
Rgts:
Alkaline CuSO4
Rochelle salt (NaK Tartrate)
NaOH
KI
End product: Violet color (545nm)
|
Folin-Ciocalteu (Lowry) method
|
Highest analytical sensitivity
Oxidation of phenolic compounds (tyrosine,
tryptophan, histidine)
Rgts:
Phenol (or phosphotungstic-molybdic acid)
Biuret (color enhancer)
End product: Blue color
|
Electrophoresis
|
MI: elevated APRs (AAT, HPG, a1-x)
|
Gamma-spike
|
Monoclonal gammopathy (multiple myeloma)
|
Beta-gamma bridging
|
In serum: Hepatic cirrhosis (IgA)
In plasma: normal (fibrinogen)
|
Alpha2-globulin band spike
|
Nephrotic syndrome
|
Alpha1-globulin flat curve
|
Juvenile cirrhosis (AAT deficiency)
|
Alpha1, alpha2,
beta-globulin band spikes
|
Inflammation
|
Polyclonal gammopathy
|
Chronic inflammation (RA, malignancy)
|
Small spikes in beta region
|
IDA (transferrin)
|
Free hemoglobin
|
“Blip” in the late alpha2 or
early beta region
|
Refractometry
|
Refractive index
|
Turbidimetric and nephelometric methods
|
SSA
TCA
|
Salt fractionation
|
Salt: Sodium sulfate
|
Albumin
|
Soluble:
Water
Moderately concentrated salt solution
Concentrated salt solution
Insoluble:
Hydrocarbon solvents
Highly concentrated salt solution
Saturated salt solution
|
Globulin
|
Soluble:
Hydrocarbon solvents
Weak salt solution
Insoluble:
Water
Saturated salt solution
Concentrated salt solution
|
Prothrombin time
|
Differentiates intrahepatic disorder
(prolonged PT) from extrahepatic obstructive liver disease (normal PT)
|
Albumin
|
Inversely proportional to the severity of
the liver disease
|
Hepatic cirrhosis
|
Low total protein + low albumin
|
Bromcresol green
|
Most commonly used dye for albumin
|
Bromcresol purple
|
Most specific dye for albumin
|
Other dyes for albumin
|
Hydroxyazobenzene benzoic acid (HABA)
Methyl orange (MO)
|
Nephrotic syndrome
|
Albumin excretion: 20-30 g/day
|
Analbuminemia
|
(-) albumin
|
Bisalbuminemia
|
EP: 2 albumin bands
Therapeutic drugs in serum
|
Inverted A/G ratio
|
Hepatic cirrhosis (IgA)
Multiple Myeloma (IgG)
Waldenström’s macroglobulinemia (IgM)
Chronic inflammation
|
Bilirubin
|
Derived from hemoglobin myoglobin, catalase
and cytochrome oxidase
|
Heme oxygenase
|
Protoporphyrin à Biliverdin
|
Biliverdin reductase
|
Biliverdin à B1
|
Urobilinogen
|
Deconjugated bilirubin
|
Bilirubin 1
|
Non-polar bilirubin
Free/Slow bilirubin
|
Bilirubin 2
|
Polar bilirubin
One-minute/prompt bilirubin
Regurgitative bilirubin
|
Delta bilirubin
|
Bilirubin tightly bound to albumin
Delta bilirubin = TB-DB+IB
|
Jaundice
|
Bilirubin >2 or 3 mg/dL
|
Pre-hepatic jaundice
|
Hemolytic
B1 = increased
B2 = normal
UG = increased
UB = negative
|
Hepatic jaundice
|
Hepatocellular
B1 = increased
B2 = increased
UG = increased
UB = positive
ALT = increased
AST = increased
|
Post-hepatic jaundice
|
Obstructive
B1 = normal
B2 = increased
UG = decreased/negative
UB = positive
ALP = increased
GGT = increased
Cholesterol = increased
|
Gilbert’s syndrome
|
Bilirubin transport deficit (uptake)
B1 = increased
B2 = decreased
|
Crigler-Najjar syndrome
|
Conjugation deficit
Type I = total UDPGT deficiency
Type II = partial UDPGT deficiency
B1 = increased
B2 = decreased
Danger: Kernicterus
Bile is colorless
|
Dubin-Johnson syndrome & Rotor syndrome
|
Bilirubin excretion deficit
Blockade of excretion into the canaliculi
TB = increased
B2 = increased
|
Lucey-Driscoll syndrome
|
Circulating inhibitor of bilirubin conjugation
B1 = increased
|
Methods (Bilirubin)
|
Free from hemolysis and lipemia
Store in the dark
Measured ASAP or w/in 2-3 hours
|
Van den Berg reaction
|
Diazotization of bilirubin
|
Evelyn and Malloy method
|
Accelerator: Methanol
Diazo rgts:
Diazo A (0.1% Sulfanilic acid + HCl)
Diazo B (0.5% Sodium nitrite)
Diazo blank (1.5% HCl)
(+) pink to purple azobilirubin
Affected by hemolysis
|
Jendrassik and Grof
|
Candidate reference method
Accelerator: Caffeine sodium benzoate
Buffer: Sodium acetate
Ascorbic acid: terminates the initial reaction and
destroys the excess diazo rgt
Not falsely elevated by hemolysis
Total bilirubin is measured 15 minutes
after adding methanol or caffeine soln
|
Bilirubin
|
Absorbs light maximally at 450nm
|
Rosenthal White method
|
Double collection method
Collection:
-After 5 mins (50% dye retention)
-After 30 mins (0% dye retention)
|
Mac Donald method
|
Single collection method
Collection:
-After 45 mins (+/- 5% dye retention)
|
Ammonia
|
From deamination of amino acids
Elevated levels are neurotoxic and often
associated w/ encephalopathy and acetaminophen poisoning
Diagnosis of hepatic failure and Reye’s
syndrome
In severe liver disorder: áNH3 à circulation à brain (conv. to glutamine) à increases pH à compromise the Kreb’s cycle à Coma due to lack of ATP for
the brain
|
Methods (Ammonia)
|
Specimen: Heparin or EDTA plasma
Fasting is required
Avoid smoking
Prolonged standing of specimen: increased
NH3 due to deamination
Place on iced water immediately
Avoid hemolysis
|
Kjeldahl (Digestion) method
|
Specimen à PFF
N2 ----------(hot conc. H2SO4
+ CuSO4 + Hg + Selenium)----------> NH3
|
Nesslerization of ammonia
|
NH3 + K2Hg2I2
----------(Gum Ghatti)----------> NH2Hg2I2
End color:
Yellow (low to moderate N2)
Orange brown (high N2)
|
Berthelot reaction
|
NH3 + Phenol + Hypochlorite
-----(Na Nitroprusside)-----> Indophenol blue
|
Normal Values
(Liver Function Tests)
|
Total protein = 6.5-8.3 g/dL
Albumin = 3.5-5.0 g/dL
Globulin = 2.3-3.5 g/dL
α1-globulin =
0.1-0.3 g/dL
α2-globulin =
0.6-1.0 g/dL
β-globulin = 0.7-1.1 g/dL
γ-globulin = 0.8-1.6 g/dL
Total bilirubin = 0.2-1.0 mg/dL
Indirect bilirubin = 0.2-0.8 mg/dL
Direct bilirubin = 0-0.2 mg/dL
Urobilinogen:
Urine = 0.1-1.0 Ehrlich units/2hrs (or 0.54
Ehrlich units/day)
Stool = 75-275 Ehrlich units/100g feces (or
75-400 Ehrlich units/24hrs)
Ammonia = 19-60 μg/dL
|